$AXON
AXON ENTERPRISE, INC. Stock $axon

$axon Overview Financials Valuation SEC Filings Company Website

2018 Q4 Form 10-Q Financial Statement

#000106918318000114 Filed on November 07, 2018

Income Statement

Concept	2018 Q4	2018 Q3	2017 Q3
Revenue	$114.8M	$104.8M	$90.26M
YoY Change	21.28%	16.15%	25.57%
Cost Of Revenue	$49.40M	$39.20M	$40.50M
YoY Change	56.33%	-3.2%	59.96%
Gross Profit	$65.35M	$65.63M	$49.77M
YoY Change	3.7%	31.89%	6.87%
Gross Profit Margin	56.93%	62.61%	55.13%
Selling, General & Admin	$42.10M	$39.69M	$36.40M
YoY Change	6.31%	9.03%	29.43%
% of Gross Profit	64.43%	60.47%	73.14%
Research & Development	$21.30M	$21.98M	$14.17M
YoY Change	34.81%	55.17%	92.53%
% of Gross Profit	32.6%	33.49%	28.47%
Depreciation & Amortization	$2.390M	$3.070M	$2.277M
YoY Change	1.27%	34.83%	152.72%
% of Gross Profit	3.66%	4.68%	4.58%
Operating Expenses	$63.40M	$61.67M	$50.56M
YoY Change	14.44%	21.96%	42.52%
Operating Profit	$1.946M	$3.966M	-$799.0K
YoY Change	-74.45%	-596.37%	-107.21%
Interest Expense	$1.000M	$1.274M	$1.430M
YoY Change	-266.67%	-10.91%	-414.29%
% of Operating Profit	51.39%	32.12%
Other Income/Expense, Net
YoY Change
Pretax Income	$3.000M	$5.240M	$631.0K
YoY Change	-57.75%	730.43%	-94.06%
Income Tax	$600.0K	-$471.0K	$209.0K
% Of Pretax Income	20.0%	-8.99%	33.12%
Net Earnings	$2.083M	$5.711M	$422.0K
YoY Change	-60.0%	1253.32%	-89.02%
Net Earnings / Revenue	1.81%	5.45%	0.47%
Basic Earnings Per Share	$0.04	$0.10	$0.01
Diluted Earnings Per Share	$0.03	$0.10	$0.01
COMMON SHARES
Basic Shares Outstanding	58.45M shares	58.34M shares	52.83M shares
Diluted Shares Outstanding		59.81M shares	53.84M shares

Balance Sheet

Concept	2018 Q4	2018 Q3	2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$349.5M	$324.9M	$61.80M
YoY Change	326.22%	425.73%	-35.76%
Cash & Equivalents	$349.5M	$324.4M	$43.47M
Short-Term Investments	$0.00	$500.0K	$18.40M
Other Short-Term Assets	$30.40M	$30.50M	$23.00M
YoY Change	40.09%	32.61%	65.47%
Inventory	$33.76M	$39.22M	$52.69M
Prepaid Expenses
Receivables	$144.5M	$129.8M	$51.20M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$558.2M	$524.4M	$188.7M
YoY Change	172.02%	177.83%	12.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$37.89M	$35.61M	$31.26M
YoY Change	21.56%	13.91%	36.07%
Goodwill	$24.98M	$25.04M	$14.92M
YoY Change	67.35%	67.81%	67.96%
Intangibles	$15.94M	$16.96M	$20.76M
YoY Change	-15.34%	-18.32%	191.71%
Long-Term Investments			$0.00
YoY Change			-100.0%
Other Assets	$23.00M	$23.40M	$16.53M
YoY Change	49.67%	41.5%	-24.02%
Total Long-Term Assets	$161.4M	$157.3M	$138.9M
YoY Change	21.42%	13.28%	65.81%
TOTAL ASSETS
Total Short-Term Assets	$558.2M	$524.4M	$188.7M
Total Long-Term Assets	$161.4M	$157.3M	$138.9M
Total Assets	$719.5M	$681.7M	$327.6M
YoY Change	112.81%	108.08%	29.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$15.16M	$8.998M	$12.35M
YoY Change	76.49%	-27.17%	37.54%
Accrued Expenses	$41.09M	$36.91M	$22.43M
YoY Change	74.84%	64.54%	39.44%
Deferred Revenue	$107.0M	$89.64M
YoY Change	52.01%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$166.0M	$141.5M	$100.1M
YoY Change	53.79%	41.38%	47.69%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$5.704M	$80.50M	$61.40M
YoY Change	366.01%	31.11%	42.46%
Total Long-Term Liabilities	$5.704M	$80.50M	$61.40M
YoY Change	366.01%	31.11%	42.46%
TOTAL LIABILITIES
Total Short-Term Liabilities	$166.0M	$141.5M	$100.1M
Total Long-Term Liabilities	$5.704M	$80.50M	$61.40M
Total Liabilities	$252.2M	$222.0M	$161.5M
YoY Change	47.78%	37.46%	45.69%
SHAREHOLDERS EQUITY
Retained Earnings	$171.4M	$169.3M	$125.3M
YoY Change	39.13%	35.16%	11.9%
Common Stock	$453.4M	$447.9M	$198.0M
YoY Change	124.82%	126.25%	7.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$155.9M	$155.9M	$155.9M
YoY Change	0.0%	0.0%	0.0%
Treasury Stock Shares	20.22M shares	20.22M shares	20.22M shares
Shareholders Equity	$467.3M	$459.7M	$166.1M
YoY Change
Total Liabilities & Shareholders Equity	$719.5M	$681.7M	$327.6M
YoY Change	112.81%	108.08%	29.9%

Cashflow Statement

Concept	2018 Q4	2018 Q3	2017 Q3
OPERATING ACTIVITIES
Net Income	$2.083M	$5.711M	$422.0K
YoY Change	-60.0%	1253.32%	-89.02%
Depreciation, Depletion And Amortization	$2.390M	$3.070M	$2.277M
YoY Change	1.27%	34.83%	152.72%
Cash From Operating Activities	$31.24M	$16.53M	$6.610M
YoY Change	28.45%	150.08%	-43.12%
INVESTING ACTIVITIES
Capital Expenditures	-$4.360M	-$2.420M	$3.331M
YoY Change	124.74%	-172.65%	142.96%
Acquisitions
YoY Change
Other Investing Activities	$500.0K	$3.650M	$11.10M
YoY Change	-95.64%	-67.12%	413.89%
Cash From Investing Activities	-$3.860M	$1.230M	$7.510M
YoY Change	-140.5%	-83.62%	1073.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.810M	-1.040M	-250.0K
YoY Change	25.45%	316.0%	-134.72%
NET CHANGE
Cash From Operating Activities	31.24M	16.53M	6.610M
Cash From Investing Activities	-3.860M	1.230M	7.510M
Cash From Financing Activities	-2.810M	-1.040M	-250.0K
Net Change In Cash	24.57M	16.72M	13.87M
YoY Change	-22.27%	20.55%	6.86%
FREE CASH FLOW
Cash From Operating Activities	$31.24M	$16.53M	$6.610M
Capital Expenditures	-$4.360M	-$2.420M	$3.331M
Free Cash Flow	$35.60M	$18.95M	$3.279M
YoY Change	35.57%	477.92%	-68.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q3	aaxn	Adjusted Ebitda Goal Goal Number Eleven AdjustedEBITDAGoalGoalNumberEleven	175000000	USD
CY2018Q3	aaxn	Adjusted Ebitda Goal Goal Number Fifteen AdjustedEBITDAGoalGoalNumberFifteen	220000000	USD
CY2018Q3	aaxn	Adjusted Ebitda Goal Goal Number Fourteen AdjustedEBITDAGoalGoalNumberFourteen	210000000	USD
CY2018Q3	aaxn	Adjusted Ebitda Goal Goal Number Nine AdjustedEBITDAGoalGoalNumberNine	125000000	USD
CY2018Q3	aaxn	Adjusted Ebitda Goal Goal Number Sixteen AdjustedEBITDAGoalGoalNumberSixteen	230000000	USD
CY2018Q3	aaxn	Adjusted Ebitda Goal Goal Number Ten AdjustedEBITDAGoalGoalNumberTen	155000000	USD
CY2018Q3	aaxn	Adjusted Ebitda Goal Goal Number Thirteen AdjustedEBITDAGoalGoalNumberThirteen	200000000	USD
CY2018Q3	aaxn	Adjusted Ebitda Goal Goal Number Twelve AdjustedEBITDAGoalGoalNumberTwelve	190000000	USD
CY2017Q4	aaxn	Cash Cash Equivalent And Investments Amortized Cost CashCashEquivalentAndInvestmentsAmortizedCost	75105000	USD
CY2018Q3	aaxn	Cash Cash Equivalent And Investments Amortized Cost CashCashEquivalentAndInvestmentsAmortizedCost	324371000	USD
	aaxn	Employee Deferrals Vested Percentage EmployeeDeferralsVestedPercentage	1.00
CY2018Q3	aaxn	Finite Lived Intangible Assets Amortization Expense Year Six FiniteLivedIntangibleAssetsAmortizationExpenseYearSix	1393000	USD
CY2018Q3	aaxn	Finite Lived Intangible Assets Amortization Expenseafter Year Six FiniteLivedIntangibleAssetsAmortizationExpenseafterYearSix	1839000	USD
	aaxn	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	11252000	USD
	aaxn	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	12081000	USD
CY2017Q4	aaxn	Inventory Finished Goods Trial And Evaluation Gross InventoryFinishedGoodsTrialAndEvaluationGross	1400000	USD
CY2018Q3	aaxn	Inventory Finished Goods Trial And Evaluation Gross InventoryFinishedGoodsTrialAndEvaluationGross	1700000	USD
	aaxn	Market Capitalization Goalfor Tranche First Tranche MarketCapitalizationGoalforTrancheFirstTranche	2500000000	USD
	aaxn	Market Capitalization Goalfor Tranche Incremental Increase MarketCapitalizationGoalforTrancheIncrementalIncrease	1000000000	USD
CY2018Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	36908000	USD
CY2018Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	26014000	USD
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3870000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	594000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	34000	USD
CY2017Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1400000	USD
CY2017Q4	aaxn	Prepaid Expenses Depositsand Other Assets Noncurrent PrepaidExpensesDepositsandOtherAssetsNoncurrent	1384000	USD
CY2018Q3	aaxn	Prepaid Expenses Depositsand Other Assets Noncurrent PrepaidExpensesDepositsandOtherAssetsNoncurrent	2795000	USD
	aaxn	Provision For Unrecognized Tax Benefits ProvisionForUnrecognizedTaxBenefits	-134000	USD
	aaxn	Provision For Unrecognized Tax Benefits ProvisionForUnrecognizedTaxBenefits	99000	USD
	aaxn	Revenue From Contract With Customer Payment Due Date From Date Of Invoice RevenueFromContractWithCustomerPaymentDueDateFromDateOfInvoice	30	day
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3300000	USD
CY2018Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1600000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4600000	USD
CY2017Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	575000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	506000	shares
CY2018Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6793000	shares
CY2018Q3	aaxn	Maximum Ratio Of Liabilities To Tangible Net Worth MaximumRatioOfLiabilitiesToTangibleNetWorth	2
	aaxn	Number Of Revenue Sources NumberOfRevenueSources	2	source
CY2018Q3	aaxn	Numberof Wholly Owned Subsidiaries NumberofWhollyOwnedSubsidiaries	2	subsidiary
CY2018Q3	aaxn	Operational Goal Probableof Achievement Adjusted Ebitda OperationalGoalProbableofAchievementAdjustedEBITDA	125000000	USD
CY2018Q3	aaxn	Operational Goal Probableof Achievement Total Revenue OperationalGoalProbableofAchievementTotalRevenue	710100000	USD
	aaxn	Period Used For Calculating Ratios PeriodUsedForCalculatingRatios	P12M
CY2018Q3	aaxn	Revenue Goal Goal Number Eight RevenueGoalGoalNumberEight	2010058000	USD
CY2018Q3	aaxn	Revenue Goal Goal Number Five RevenueGoalGoalNumberFive	1410058000	USD
CY2018Q3	aaxn	Revenue Goal Goal Number Four RevenueGoalGoalNumberFour	1210058000	USD
CY2018Q3	aaxn	Revenue Goal Goal Number One RevenueGoalGoalNumberOne	710058000	USD
CY2018Q3	aaxn	Revenue Goal Goal Number Seven RevenueGoalGoalNumberSeven	1810058000	USD
CY2018Q3	aaxn	Revenue Goal Goal Number Six RevenueGoalGoalNumberSix	1610058000	USD
CY2018Q3	aaxn	Revenue Goal Goal Number Three RevenueGoalGoalNumberThree	1010058000	USD
CY2018Q3	aaxn	Revenue Goal Goal Number Two RevenueGoalGoalNumberTwo	860058000	USD
	aaxn	Warranty Period After Purchase Of Product WarrantyPeriodAfterPurchaseOfProduct	P1Y
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Period End Date DocumentPeriodEndDate	2018-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001069183
CY2018Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	58448574	shares
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	AXON ENTERPRISE, INC.
	dei	Entity Small Business EntitySmallBusiness	false
CY2017Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	56064000	USD
CY2018Q3	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	116518000	USD
CY2018Q1	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	84979000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8592000	USD
CY2018Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	8998000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	23502000	USD
CY2018Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2910000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1467000	USD
CY2018Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1626000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	201672000	USD
CY2018Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	447933000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1800000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	754000	USD
CY2018Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1559000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6760000	shares
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	-23000	USD
CY2018Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2000000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2017Q4	us-gaap	Assets Assets	338112000	USD
CY2018Q3	us-gaap	Assets Assets	681695000	USD
CY2018Q1	us-gaap	Assets Assets	169376000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	205192000	USD
CY2018Q3	us-gaap	Assets Current AssetsCurrent	524387000	USD
CY2018Q1	us-gaap	Assets Current AssetsCurrent	114190000	USD
	us-gaap	Business Combination Consideration Transferred Liabilities Incurred BusinessCombinationConsiderationTransferredLiabilitiesIncurred	1007000	USD
	us-gaap	Business Combination Consideration Transferred Liabilities Incurred BusinessCombinationConsiderationTransferredLiabilitiesIncurred	12508000	USD
CY2017Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1693000	USD
CY2018Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1736000	USD
CY2017Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	1048000	USD
CY2018Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	556000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1114000	USD
CY2017Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	1224000	USD
CY2018Q3	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	5751000	USD
CY2018Q3	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1500000	USD
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	3800000	USD
CY2018Q3	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	20382000	USD
CY2018Q3	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	6207000	USD
CY2017Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	6803000	USD
CY2018Q3	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	14175000	USD
CY2018Q1	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	12200000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43471000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	75105000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	324371000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	43969000	USD
CY2017Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46797000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	78438000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	326848000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2828000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	248410000	USD
CY2017Q4	us-gaap	Cash Surrender Value Fair Value Disclosure CashSurrenderValueFairValueDisclosure	3846000	USD
CY2018Q3	us-gaap	Cash Surrender Value Fair Value Disclosure CashSurrenderValueFairValueDisclosure	3949000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	52969869	shares
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	58419742	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52969869	shares
CY2018Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	58419742	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1138000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5167000	USD
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5604000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	26963000	USD
CY2018Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	13263000	USD
CY2017Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	0	USD
CY2018Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	13263000	USD
CY2018Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	5512000	USD
CY2017Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	125282000	USD
CY2018Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	159019000	USD
CY2017Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	70401000	USD
CY2018Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	89637000	USD
CY2018Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	71264000	USD
CY2017Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	54881000	USD
CY2018Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	69382000	USD
CY2018Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	56130000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	63475000	USD
CY2017Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	40497000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	105075000	USD
CY2018Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	39203000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	112040000	USD
CY2017Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	3859000	USD
CY2018Q3	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	3590000	USD
CY2017Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	15755000	USD
CY2018Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	18080000	USD
CY2018Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	10597000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4155000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2326000	USD
CY2018Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	18100000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1706000	USD
CY2018Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1805000	USD
CY2017Q3	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	600000	USD
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-169000	USD
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1900000	USD
CY2018Q3	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	900000	USD
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2400000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5677000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8226000	USD
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.49
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.47
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	703000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-381000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.081
	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0.240
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8957000	USD
CY2018Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	15057000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P8Y3M14D
CY2018Q3	us-gaap	Escrow Deposit EscrowDeposit	0	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7202000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	13672000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1209000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1200000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2854000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3296000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3357000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	24253000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	28820000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	17051000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	15148000	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-290000	USD
	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	0	USD
	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	-2103000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	14927000	USD
CY2018Q3	us-gaap	Goodwill Goodwill	25043000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	10285000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	45465000	USD
CY2018Q3	us-gaap	Inventory Net InventoryNet	39221000	USD
CY2017Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	20119000	USD
CY2018Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	19942000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	170668000	USD
CY2017Q3	us-gaap	Gross Profit GrossProfit	49765000	USD
	us-gaap	Gross Profit GrossProfit	144072000	USD
CY2018Q3	us-gaap	Gross Profit GrossProfit	65633000	USD
	us-gaap	Gross Profit GrossProfit	193237000	USD
CY2017Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	81967000	USD
CY2018Q3	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	324871000	USD
CY2017Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	6000	USD
CY2018Q3	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	0	USD
CY2017Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	81961000	USD
CY2018Q3	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	324871000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	631000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	8695000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5240000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	25090000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	209000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1417000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-471000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2032000	USD
	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	2200000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	12206000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	7957000	USD
	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	26027000	USD
	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	51172000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3382000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4306000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	26460000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	31700000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	19074000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-9033000	USD
CY2018Q3	us-gaap	Increase In Unrecognized Tax Benefits Is Reasonably Possible IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	200000	USD
CY2017Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1012000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1099000	shares
CY2018Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1465000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1573000	shares
CY2017Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1772000	USD
CY2018Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1808000	USD
CY2017Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	26025000	USD
CY2018Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	30628000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	18823000	USD
CY2018Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	16956000	USD
CY2017Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1430000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	3320000	USD
CY2018Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1274000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	2242000	USD
CY2017Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	25346000	USD
CY2018Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	19279000	USD
CY2018Q3	us-gaap	Liabilities Liabilities	222033000	USD
CY2018Q1	us-gaap	Liabilities Liabilities	153408000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	338112000	USD
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	681695000	USD
CY2018Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	295587000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	107950000	USD
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	141505000	USD
CY2018Q1	us-gaap	Liabilities Current LiabilitiesCurrent	97278000	USD
CY2017Q4	us-gaap	Long Term Accounts Notes And Loans Receivable Net Noncurrent LongTermAccountsNotesAndLoansReceivableNetNoncurrent	36877000	USD
CY2018Q3	us-gaap	Long Term Accounts Notes And Loans Receivable Net Noncurrent LongTermAccountsNotesAndLoansReceivableNetNoncurrent	38220000	USD
CY2018Q1	us-gaap	Long Term Accounts Notes And Loans Receivable Net Noncurrent LongTermAccountsNotesAndLoansReceivableNetNoncurrent	23900000	USD
CY2011Q3	us-gaap	Loss Contingency Pending Claims Number LossContingencyPendingClaimsNumber	55	lawsuit
CY2018Q3	us-gaap	Loss Contingency Pending Claims Number LossContingencyPendingClaimsNumber	7	lawsuit
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1575000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	222158000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	9551000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6003000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5851000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	32636000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	422000	USD
	us-gaap	Net Income Loss NetIncomeLoss	7278000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	5711000	USD
	us-gaap	Net Income Loss NetIncomeLoss	27122000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	50564000	USD
	us-gaap	Operating Expenses OperatingExpenses	138697000	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	61667000	USD
	us-gaap	Operating Expenses OperatingExpenses	170389000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-799000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	5375000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	3966000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	22848000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7473000	USD
CY2018Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	13069000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	15366000	USD
CY2018Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	23396000	USD
CY2018Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	20689000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1560000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2111000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-107000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-159000	USD
CY2017Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	89000	USD
CY2018Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	115000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2830000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	11973000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	10629000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6880000	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2018Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2018Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14166000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	39618000	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21982000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	55602000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	4990000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	431000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	460000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	19950000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	4331000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9072000	USD
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	21696000	USD
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	30514000	USD
CY2018Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	23699000	USD
CY2018Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	234000000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	233993000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	49633000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	10658000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1255000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	713000	USD
CY2016Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	780000	USD
CY2017Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	719000	USD
CY2017Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	644000	USD
CY2018Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	959000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	178000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	384000	USD
	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	117000	USD
	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	699000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	31172000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	35613000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Owned Accumulated Depreciation PropertyPlantAndEquipmentOwnedAccumulatedDepreciation	36447000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Owned Accumulated Depreciation PropertyPlantAndEquipmentOwnedAccumulatedDepreciation	38599000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	575000	USD
CY2017Q3	us-gaap	Restricted Cash RestrictedCash	3326000	USD
CY2017Q4	us-gaap	Restricted Cash RestrictedCash	3333000	USD
CY2018Q3	us-gaap	Restricted Cash RestrictedCash	2477000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	123185000	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	169301000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	142179000	USD
CY2017Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	90262000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	249147000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	104836000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	305277000	USD
CY2018Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	820000000	USD
CY2018Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2018Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P5Y
CY2018Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P7Y
CY2018Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	53.00
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	36398000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	99079000	USD
CY2018Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	39685000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	114787000	USD
CY2017Q3	us-gaap	Share Based Compensation ShareBasedCompensation	4000000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	11423000	USD
CY2018Q3	us-gaap	Share Based Compensation ShareBasedCompensation	6255000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	15302000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.4771
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0298
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1700000	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1100000	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2017Q4	us-gaap	Short Term Investments ShortTermInvestments	6862000	USD
CY2018Q3	us-gaap	Short Term Investments ShortTermInvestments	500000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	167444000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	459662000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	142179000	USD
CY2017Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2558000	USD
CY2018Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	4913000	USD
CY2017Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	20220227	shares
CY2018Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	20220227	shares
CY2017Q4	us-gaap	Treasury Stock Value TreasuryStockValue	155947000	USD
CY2018Q3	us-gaap	Treasury Stock Value TreasuryStockValue	155947000	USD
CY2018Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3800000	USD
CY2018Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	3600000	USD
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53843000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53762000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59805000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57254000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52831000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52663000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58340000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55681000	shares
	us-gaap	Reclassifications Reclassifications	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the SEC. Certain information related to our organization, significant accounting policies and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) has been condensed or omitted. The accounting policies followed in the preparation of these unaudited condensed consolidated financial statements are consistent with those followed in our annual consolidated financial statements for the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, as filed on Form 10-K, with the exception of our adoption of certain accounting pronouncements which we describe below and in Note 2. In the opinion of management, these unaudited condensed consolidated financial statements contain all material adjustments, consisting only of normal recurring adjustments, necessary to fairly state our financial position, results of operations and cash flows for the periods presented and the presentations and disclosures herein are adequate when read in conjunction with our Form 10-K for the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">. The results of operations for the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> are not necessarily indicative of the results to be expected for the full year (or any other period). Significant estimates and assumptions in these unaudited condensed consolidated financial statements include:</font></div><div style="line-height:120%;text-align:justify;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;"> </font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:47px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:23px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">product warranty reserves,</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:47px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:23px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">inventory valuation,</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:47px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:23px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">revenue recognition,</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:47px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:23px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">valuation of goodwill, intangible and long-lived assets,</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:47px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:23px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">recognition, measurement and valuation of current and deferred income taxes,</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:47px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:23px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">stock-based compensation, </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:47px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:23px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">recognition and measurement of contingencies and accrued litigation expense, and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:47px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:23px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">fair values of identified tangible and intangible assets acquired and liabilities assumed in business combinations.</font></div></td></tr></table><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Actual results could differ materially from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001069183-18-000114-index-headers.html	Edgar Link	pending
0001069183-18-000114-index.html	Edgar Link	pending
0001069183-18-000114.txt	Edgar Link	pending
0001069183-18-000114-xbrl.zip	Edgar Link	pending
aaxn-20180930.xml	Edgar Link	completed
aaxn-20180930.xsd	Edgar Link	pending
aaxn-20180930_cal.xml	Edgar Link	unprocessable
aaxn-20180930_def.xml	Edgar Link	unprocessable
aaxn-20180930_lab.xml	Edgar Link	unprocessable
aaxn-20180930_pre.xml	Edgar Link	unprocessable
aaxnq32018-10xqdocument.htm	Edgar Link	pending
axonhqpsafullyexecuted.htm	Edgar Link	pending
axonhqpsafullyexecuted001.jpg	Edgar Link	pending
axonhqpsafullyexecuted002.jpg	Edgar Link	pending
axonhqpsafullyexecuted003.jpg	Edgar Link	pending
axonhqpsafullyexecuted004.jpg	Edgar Link	pending
axonhqpsafullyexecuted005.jpg	Edgar Link	pending
axonhqpsafullyexecuted006.jpg	Edgar Link	pending
axonhqpsafullyexecuted007.jpg	Edgar Link	pending
axonhqpsafullyexecuted008.jpg	Edgar Link	pending
axonhqpsafullyexecuted009.jpg	Edgar Link	pending
axonhqpsafullyexecuted010.jpg	Edgar Link	pending
axonhqpsafullyexecuted011.jpg	Edgar Link	pending
axonhqpsafullyexecuted012.jpg	Edgar Link	pending
axonhqpsafullyexecuted013.jpg	Edgar Link	pending
axonhqpsafullyexecuted014.jpg	Edgar Link	pending
axonhqpsafullyexecuted015.jpg	Edgar Link	pending
axonhqpsafullyexecuted016.jpg	Edgar Link	pending
axonhqpsafullyexecuted017.jpg	Edgar Link	pending
axonhqpsafullyexecuted018.jpg	Edgar Link	pending
axonhqpsafullyexecuted019.jpg	Edgar Link	pending
axonhqpsafullyexecuted020.jpg	Edgar Link	pending
axonhqpsafullyexecuted021.jpg	Edgar Link	pending
axonhqpsafullyexecuted022.jpg	Edgar Link	pending
axonhqpsafullyexecuted023.jpg	Edgar Link	pending
axonhqpsafullyexecuted024.jpg	Edgar Link	pending
axonhqpsafullyexecuted025.jpg	Edgar Link	pending
axonhqpsafullyexecuted026.jpg	Edgar Link	pending
axonhqpsafullyexecuted027.jpg	Edgar Link	pending
axonhqpsafullyexecuted028.jpg	Edgar Link	pending
axonhqpsafullyexecuted029.jpg	Edgar Link	pending
axonhqpsafullyexecuted030.jpg	Edgar Link	pending
axonhqpsafullyexecuted031.jpg	Edgar Link	pending
axonhqpsafullyexecuted032.jpg	Edgar Link	pending
axonhqpsafullyexecuted033.jpg	Edgar Link	pending
axonhqpsafullyexecuted034.jpg	Edgar Link	pending
axonhqpsafullyexecuted035.jpg	Edgar Link	pending
axonhqpsafullyexecuted036.jpg	Edgar Link	pending
axonhqpsafullyexecuted037.jpg	Edgar Link	pending
axonhqpsafullyexecuted038.jpg	Edgar Link	pending
axonhqpsafullyexecuted039.jpg	Edgar Link	pending
axonhqpsafullyexecuted040.jpg	Edgar Link	pending
axonhqpsafullyexecuted041.jpg	Edgar Link	pending
axonhqpsafullyexecuted042.jpg	Edgar Link	pending
axonhqpsafullyexecuted043.jpg	Edgar Link	pending
axonhqpsafullyexecuted044.jpg	Edgar Link	pending
axonhqpsafullyexecuted045.jpg	Edgar Link	pending
axonhqpsafullyexecuted046.jpg	Edgar Link	pending
axonhqpsafullyexecuted047.jpg	Edgar Link	pending
axonhqpsafullyexecuted048.jpg	Edgar Link	pending
axonhqpsafullyexecuted049.jpg	Edgar Link	pending
axonhqpsafullyexecuted050.jpg	Edgar Link	pending
axonhqpsafullyexecuted051.jpg	Edgar Link	pending
axonhqpsafullyexecuted052.jpg	Edgar Link	pending
axonhqpsafullyexecuted053.jpg	Edgar Link	pending
axonhqpsafullyexecuted054.jpg	Edgar Link	pending
axonhqpsafullyexecuted055.jpg	Edgar Link	pending
axonhqpsafullyexecuted056.jpg	Edgar Link	pending
axonhqpsafullyexecuted057.jpg	Edgar Link	pending
axonhqpsafullyexecuted058.jpg	Edgar Link	pending
axonhqpsafullyexecuted059.jpg	Edgar Link	pending
axonhqpsafullyexecuted060.jpg	Edgar Link	pending
axonhqpsafullyexecuted061.jpg	Edgar Link	pending
axonhqpsafullyexecuted062.jpg	Edgar Link	pending
axonhqpsafullyexecuted063.jpg	Edgar Link	pending
axonhqpsafullyexecuted064.jpg	Edgar Link	pending
axonhqpsafullyexecuted065.jpg	Edgar Link	pending
axonhqpsafullyexecuted066.jpg	Edgar Link	pending
axonhqpsafullyexecuted067.jpg	Edgar Link	pending
axonhqpsafullyexecuted068.jpg	Edgar Link	pending
axonhqpsafullyexecuted069.jpg	Edgar Link	pending
axonhqpsafullyexecuted070.jpg	Edgar Link	pending
axonhqpsafullyexecuted071.jpg	Edgar Link	pending
axonhqpsafullyexecuted072.jpg	Edgar Link	pending
axonhqpsafullyexecuted073.jpg	Edgar Link	pending
axonhqpsafullyexecuted074.jpg	Edgar Link	pending
axonhqpsafullyexecuted075.jpg	Edgar Link	pending
axonhqpsafullyexecuted076.jpg	Edgar Link	pending
axonhqpsafullyexecuted077.jpg	Edgar Link	pending
axonhqpsafullyexecuted078.jpg	Edgar Link	pending
axonhqpsafullyexecuted079.jpg	Edgar Link	pending
axonhqpsafullyexecuted080.jpg	Edgar Link	pending
axonhqpsafullyexecuted081.jpg	Edgar Link	pending
axonhqpsafullyexecuted082.jpg	Edgar Link	pending
axonhqpsafullyexecuted083.jpg	Edgar Link	pending
axonhqpsafullyexecuted084.jpg	Edgar Link	pending
axonhqpsafullyexecuted085.jpg	Edgar Link	pending
axonhqpsafullyexecuted086.jpg	Edgar Link	pending
axonhqpsafullyexecuted087.jpg	Edgar Link	pending
axonhqpsafullyexecuted088.jpg	Edgar Link	pending
axonhqpsafullyexecuted089.jpg	Edgar Link	pending
axonhqpsafullyexecuted090.jpg	Edgar Link	pending
axonhqpsafullyexecuted091.jpg	Edgar Link	pending
axonhqpsafullyexecuted092.jpg	Edgar Link	pending
axonhqpsafullyexecuted093.jpg	Edgar Link	pending
axonhqpsafullyexecuted094.jpg	Edgar Link	pending
axonhqpsafullyexecuted095.jpg	Edgar Link	pending
axonhqpsafullyexecuted096.jpg	Edgar Link	pending
axonhqpsafullyexecuted097.jpg	Edgar Link	pending
axonhqpsafullyexecuted098.jpg	Edgar Link	pending
axonhqpsafullyexecuted099.jpg	Edgar Link	pending
axonhqpsafullyexecuted100.jpg	Edgar Link	pending
axonhqpsafullyexecuted101.jpg	Edgar Link	pending
axonhqpsafullyexecuted102.jpg	Edgar Link	pending
axonhqpsafullyexecuted103.jpg	Edgar Link	pending
axonhqpsafullyexecuted104.jpg	Edgar Link	pending
axonhqpsafullyexecuted105.jpg	Edgar Link	pending
axonhqpsafullyexecuted106.jpg	Edgar Link	pending
axonhqpsafullyexecuted107.jpg	Edgar Link	pending
axonhqpsafullyexecuted108.jpg	Edgar Link	pending
axonhqpsafullyexecuted109.jpg	Edgar Link	pending
axonhqpsafullyexecuted110.jpg	Edgar Link	pending
axonhqpsafullyexecuted111.jpg	Edgar Link	pending
axonhqpsafullyexecuted112.jpg	Edgar Link	pending
axonhqpsafullyexecuted113.jpg	Edgar Link	pending
axonhqpsafullyexecuted114.jpg	Edgar Link	pending
axonhqpsafullyexecuted115.jpg	Edgar Link	pending
axonhqpsafullyexecuted116.jpg	Edgar Link	pending
axonhqpsafullyexecuted117.jpg	Edgar Link	pending
axonhqpsafullyexecuted118.jpg	Edgar Link	pending
axonhqpsafullyexecuted119.jpg	Edgar Link	pending
axonhqpsafullyexecuted120.jpg	Edgar Link	pending
axonhqpsafullyexecuted121.jpg	Edgar Link	pending
axonhqpsafullyexecuted122.jpg	Edgar Link	pending
axonhqpsafullyexecuted123.jpg	Edgar Link	pending
axonhqpsafullyexecuted124.jpg	Edgar Link	pending
axonhqpsafullyexecuted125.jpg	Edgar Link	pending
axonhqpsafullyexecuted126.jpg	Edgar Link	pending
axonhqpsafullyexecuted127.jpg	Edgar Link	pending
axonhqpsafullyexecuted128.jpg	Edgar Link	pending
axonhqpsafullyexecuted129.jpg	Edgar Link	pending
axonhqpsafullyexecuted130.jpg	Edgar Link	pending
axonhqpsafullyexecuted131.jpg	Edgar Link	pending
axonhqpsafullyexecuted132.jpg	Edgar Link	pending
axonhqpsafullyexecuted133.jpg	Edgar Link	pending
axonhqpsafullyexecuted134.jpg	Edgar Link	pending
axonhqpsafullyexecuted135.jpg	Edgar Link	pending
axonhqpsafullyexecuted136.jpg	Edgar Link	pending
axonhqpsafullyexecuted137.jpg	Edgar Link	pending
axonhqpsafullyexecuted138.jpg	Edgar Link	pending
axonhqpsafullyexecuted139.jpg	Edgar Link	pending
axonhqpsafullyexecuted140.jpg	Edgar Link	pending
axonhqpsafullyexecuted141.jpg	Edgar Link	pending
axonhqpsafullyexecuted142.jpg	Edgar Link	pending
axonhqpsafullyexecuted143.jpg	Edgar Link	pending
axonhqpsafullyexecuted144.jpg	Edgar Link	pending
axonhqpsafullyexecuted145.jpg	Edgar Link	pending
axonhqpsafullyexecuted146.jpg	Edgar Link	pending
axonhqpsafullyexecuted147.jpg	Edgar Link	pending
axonhqpsafullyexecuted148.jpg	Edgar Link	pending
axonhqpsafullyexecuted149.jpg	Edgar Link	pending
axonhqpsafullyexecuted150.jpg	Edgar Link	pending
axonhqpsafullyexecuted151.jpg	Edgar Link	pending
axonhqpsafullyexecuted152.jpg	Edgar Link	pending
axonhqpsafullyexecuted153.jpg	Edgar Link	pending
axonhqpsafullyexecuted154.jpg	Edgar Link	pending
axonhqpsafullyexecuted155.jpg	Edgar Link	pending
axonhqpsafullyexecuted156.jpg	Edgar Link	pending
axonhqpsafullyexecuted157.jpg	Edgar Link	pending
axonhqpsafullyexecuted158.jpg	Edgar Link	pending
axonhqpsafullyexecuted159.jpg	Edgar Link	pending
axonhqpsafullyexecuted160.jpg	Edgar Link	pending
axonhqpsafullyexecuted161.jpg	Edgar Link	pending
axonhqpsafullyexecuted162.jpg	Edgar Link	pending
axonhqpsafullyexecuted163.jpg	Edgar Link	pending
axonhqpsafullyexecuted164.jpg	Edgar Link	pending
axonhqpsafullyexecuted165.jpg	Edgar Link	pending
axonhqpsafullyexecuted166.jpg	Edgar Link	pending
axonhqpsafullyexecuted167.jpg	Edgar Link	pending
axonhqpsafullyexecuted168.jpg	Edgar Link	pending
axonhqpsafullyexecuted169.jpg	Edgar Link	pending
axonhqpsafullyexecuted170.jpg	Edgar Link	pending
axonhqpsafullyexecuted171.jpg	Edgar Link	pending
axonhqpsafullyexecuted172.jpg	Edgar Link	pending
axonhqpsafullyexecuted173.jpg	Edgar Link	pending
axonhqpsafullyexecuted174.jpg	Edgar Link	pending
axonhqpsafullyexecuted175.jpg	Edgar Link	pending
axonhqpsafullyexecuted176.jpg	Edgar Link	pending
axonhqpsafullyexecuted177.jpg	Edgar Link	pending
axonhqpsafullyexecuted178.jpg	Edgar Link	pending
axonhqpsafullyexecuted179.jpg	Edgar Link	pending
axonhqpsafullyexecuted180.jpg	Edgar Link	pending
chart-5433719b85995cd4889.jpg	Edgar Link	pending
ex311-9302018.htm	Edgar Link	pending
ex312-9302018.htm	Edgar Link	pending
ex32-9302018.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AXON
AXON ENTERPRISE, INC. Stock $axon

2018 Q4 Form 10-Q Financial Statement

#000106918318000114 Filed on November 07, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AXON AXON ENTERPRISE, INC. Stock $axon

2018 Q4 Form 10-Q Financial Statement

#000106918318000114 Filed on November 07, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AXON
AXON ENTERPRISE, INC. Stock $axon